Company Overview and News
Portugal is in the top ten producers of lithium which is increasingly sought after by manufacturers of electric cars which use the element in their battery packs and for companies supplying batteries for mobile phones..
Dakota Minerals (ASX:DKO) is continuing to receive strong lithium results from the ongoing phase three drilling program at the Sepeda Lithium Project in Portugal.
Parkway Minerals NL (ASX:PWN) has expanded into Western Australia’s salt lake sector with the establishment of the Lake Barlee Potash/Lithium Brine Project, northwest of Kalgoorlie.
Keen to set up shop on top of Portugal’s natural lithium resources, the management of Australian mining company Dakota Minerals wants to invest up to €370 million in an industrial facility in Tras os Montes to supply businesses across Europe.
This results in 1.95 million tonnes of lithium oxide or 4.83 million tonnes of lithium carbonate equivalent, reinforcing the company’s status as Australia’s premier lithium development project.
The acquisition further expands Pilbara’s world-class resource inventory in the Pilgangoora district of Western Australia. Pilbara has now acquired all the granted tenements for the Lynas Find project, in accordance with an agreement with Dakota Minerals (ASX:DKO) announced in October 2016. The project has a maiden JORC resource of 7.3 million tonnes at 1.25% lithium, 85 ppm tantalum and 0.99% iron oxide.
The project is located near Port Hedland in Western Australia. Numerous wide, shallow intercepts of lithium (down-hole widths of 10-22 metres) were intersected in a single, large pegmatite in the Far East zone which extends over 1,000 metres. The significant new intercepts at Far East include 27 metres at 1.73% lithium from 47 metres and 19 metres at 1.56% lithium from 75 metres. Pilbara’s resource extension drilling at South End indicates that the pegmatite remains open to the south, with significant widths of high-grade mineralisation.
Assay results from the first two drill holes indicate broad widths of mineralized pegmatite including 40 metres at 1.11% lithium from 93 metres and 16 metres at 1.39% lithium from 60 metres. The recently completed drill program totalled 18 reconnaissance reverse circulation drill holes for 2,090 metres. Visual logging of the other holes indicate very thick intercepts of petalite and spodumene-bearing pegmatite of up to 87 metres down-hole, for which assays are pending.
23h - Asif
Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...